# MIDCAB (Mid-Calf Block) for Foot Surgery

> **NCT05368012** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 20 (actual)

## Conditions studied

- Ankle Surgery
- Foot Surgery

## Interventions

- **DRUG:** MIDCAB

## Key facts

- **NCT ID:** NCT05368012
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-21
- **Primary completion:** 2022-11-29
- **Final completion:** 2022-11-29
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05368012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05368012, "MIDCAB (Mid-Calf Block) for Foot Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05368012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*